| Title： | Chinese expert consensus recommendations for management of genitourinary syndrome of menopause in female breast cancer patients |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | Clinicians specializing in breast diseases in China |
| Evidence classification method： | The evidence grading system was developed by incorporating elements of the GRADE system along with insights gleaned from clinical studies conducted in China and expert clinical experience. |
| Development unit： | the Society of Clinical Cancer Research Administration of China Anti-Cancer Association, the Society of Breast Cancer Integration and Rehabilitation of China Anti-Cancer Association, Chongqing Sexology Association, Chongqing Federation of Clinical Medical Research, Committee of Urology of Chongqing medical association, the Society of Onco-endocrinology of Chongqing Anti-Cancer Association |
| Registration time: | 2024-05-02 |
| Registration number： | PREPARE-2024CN607 |
| Purpose of the guideline: | Genitourinary syndrome of menopause (GSM) is more prevalent among breast cancer patients, with a notable absence of timely and effective diagnosis and treatment, severely impacting patients' quality of life and prognosis. With the improved survival rates of breast cancer patients, the management of cancer has entered an era of chronic disease management. However, there is still a lack of targeted guidelines or consensus for the management of GSM in female breast cancer patients within China. Based on the guideline / expert consensus and the clinical experience of multiple medical centers, the Society of Clinical Cancer Research Administration of China Anti-Cancer Association, Breast Cancer Rehabilitation Committee of China Anti-Cancer Association, Chongqing Federation of Clinical Medical Research, Committee of Urology of Chongqing medical association, and the Society of Onco-endocrinology of Chongqing Anti-Cancer Association thoroughly discussed and formulated the Chinese expert consensus recommendations for management of genitourinary syndrome of menopause in female breast cancer patients (version 2024), in order to further standardize the management of GSM in breast cancer patients. |
Latest registration
